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1. INTRODUCTION 
The beneficial effects of food have been known from 
ancient times and have been applied in treating various 
human diseases. Various phytochemical substances in the 
functional food have antioxidant properties. 
Phytochemicals can modulate different signal transduction 
pathways and play a key role in treatment of cancer. The 
phytochemicals studies about citrus fruits have shown to 
contain most of the flavonoids (1, 2). These flavonoids 
mediate important physiological functions and are 
commercially very important in nutrients and pharmacy 
companies owing to broad therapeutic applications (3, 4). 
The equilibrium between cell growth and death is very 
important for the development and maintenance of normal 
body functions in multicellular organisms (5). The process 
of cell death helps repair damaged tissue and eliminate 
harmful cells (6). Altered signaling can lead to an 
imbalance in cellular functions which may lead to 
pathological disorders such as embryogenesis, 
neurological diseases and cancer.  
Normal cells are stimulated by carcinogen and leads to 
mutation. Subsequently inhibit the function of tumor 
suppressor gene and stimulate oncogene. This cause 
uncontrolled growth of the cell known as carcinogenesis 
(5). In carcinogenesis, formation of new blood vessels is a 
key step to provide nutrients and oxygen supply to cancer 
cells. Tumor cells can invade and spread throughout the 
body through blood and lymph vessels (6).  
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ABSTRACT: Bioactive compounds isolated from 
plants have gained a lot of attention in recent years. 
Among them flavonoids, which consist of a large group 
of polyphenolic compounds, are at the forefront in the 
treatment of various diseases including cancer. 
Flavonoids possess anti-cancer properties and they exert 
their curative effect by modulating different cell-
signalling pathways like the Nf-kB pathway, 
PI3K/AKT/mTOR pathway and the JAK/STAT 
pathway. Flavonoids also possess anti-oxidant activity 
and they regulate the redox status and prevent damage 
caused by oxidative stress. Chemokines and cytokines 
play a key role in mediating the inflammatory response 
in a cell. Consequently, more inflammatory markers are 
recruited to the site of inflammation that leads to 
increased ROS and cause damage at the site of 
accumulation. The present review covers the recent 
studies, in vitro and in vivo, that highlight the promising 
potential of flavonoids in treating cancer. 
RESUMEN: Los compuestos bioactivos aislados de las 
plantas han ganado mucha atención en los últimos años. 
Entre ellos los flavonoides, que consisten en un gran 
grupo de compuestos polifenólicos, están en la 
vanguardia del tratamiento de diversas enfermedades 
incluyendo el cáncer. Los flavonoides poseen 
propiedades anticancerígenas y ejercen su efecto 
curativo mediante la modulación de diferentes vías de 
señalización intracelular como la vía Nf-kB, PI3K / 
AKT / mTOR y la vía JAK / STAT. Los flavonoides 
también poseen actividad antioxidante regulando el 
estado redox y previniendo los daños causados por el 
estrés oxidativo. Las quimiocinas y citocinas juegan un 
papel clave en la mediación de la respuesta inflamatoria 
en las células. Por lo tanto, el aumento de los 
marcadores inflamatorios que son reclutados en el sitio 
de inflamación conduce a un aumento de las especies 
reactivas del oxígeno causando daños en el lugar de su 
acumulación. La presente revisión abarca los estudios 
más recientes, tanto in vitro como in vivo, en donde se 
destaca el potencial que presentan los flavonoides en el 
tratamiento del cáncer. 
Ebtesam A Al-Suhaimi et al. 
@Real Academia Nacional de Farmacia. Spain 298 
Flavonoids are polyphenolic compounds with powerful 
and strong antioxidant, anti-inflammatory and anti-cancer 
activity. Citrus flavonoids mainly influence blood and 
microvascular endothelial cells by blocking regulatory 
enzymes, which mediate cell division and activation (7). 
The polyphenolic content of citrus fruit was reported to 
consist 81-97 % flavanones, while the remaining 
accounted for flavones, flavonols, hydroxycinnamic acids 
and coumarins (8). Despite being under investigation for 
long time, the mechanisms underlying the biological action 
of these compounds are not yet completely understood (9). 
Flavonoids having various pharmacological activities 
are attributed by inhibiting action of enzymes in cellular 
stimulation. The in vitro elucidation shows that flavonoids 
alter enzymes status such as lipooxygenases, kinases, 
phospholipases, ATPase, cyclooxygenases, and 
phosphodiesterases (10, 11, 12). Furthermore, flavonoids 
tend to react and bind with nucleotide regulatory enzymes 
(7). Citrus flavonoids also actively scavenge the free 
radicals and, therefore, show antagonist effect on aging 
and degenerative events mediated by oxidative stress (13). 
The prime focus of this review narrates the mechanistic 
action of flavonoids and discusses their biological activity 
in regards to modulating key regulatory enzymes, 
signaling cascades etc. to facilitate the treatment of cancer. 
2. CHEMICAL COMPOSITION OF FLAVONOIDS 
A number of phytochemical compounds have been 
identified as flavanoids amongst which polyphenolic 
terpenoids have been studied most extensively. They have 
a characteristic structure C6-C3-C6 structure. Majority of 
flavonoids are formed by a combination of hydroxyl, 
methoxy, and O-glycoside groups that are attached to this 
C3-C6-C3 structure (14). Flavonoids are further divided 
into flavones, flavonols, flavanones, flavanols, 
anthocyanins and isoflavones. The different classes occur 
due to a difference in the C3 element of the flavonoid 
structure (14). 
Flavonoids are considered as hydroxylated phenolic 
compounds that are produced as a result of a microbial 
infection in plants. Their characteristic 15 carbon structure 
(C6-C3-C6) includes two benzene rings commonly 
referred to as A and B rings. The A and B rings are joined 
together by a heterocyclic pyrane ring referred to as the C 
ring. The different classes of flavonoids occur because of 
different levels of oxidation and because of substitutions at 
the C ring. Different compounds within each class exist 
because of substitutions at the two benzene rings.  
Flavonoids occur in three forms, either as aglycones 
(aglycosides) and glycosides or sometimes as methylated 
derivatives. The basic structure mentioned above (i.e C6-
C3-C6) is the aglycone structure (15). Aglycosides 
(without sugar) or glycosides (containing sugar) are two 
main forms of citrus flavonoids. Glycosides contain single 
or multiple sugars attached to the basic flavonoid skeleton 
(9). 
 
3. BIOLOGICAL ACTIVITY OF FLAVONOIDS 
3.1. Anti-inflammatory effects 
Inflammation is a physiological response that is 
brought on by different circumstances such as infection or 
tissue injury. Studies have revealed that an array of 
responses triggered by the immune system leads to 
inflammation (16). There is increased level of 
inflammatory markers, free radicals lipid peroxides 
whenever there is incidence of inflammation. This is due 
to the fact that inflammation disturbs signaling pathways. 
There is also evidence suggesting that inflammation plays 
a key role in healing wounds and fighting infections. 
However, if inflammation persists for longer periods of 
time it stimulates progression of many chronic diseases 
including cancer (16, 17). 
The events that occur during inflammation include the 
recruitment of leukocytes and mast cells. This leads to 
what is known as a ‘respiratory burst’. There is an 
increased level of oxygen uptake at the site of damage and 
hence an increase in the reactive oxygen species (18). 
Inflammatory calls also produce some mediators like 
cytokines and chemokines. These molecules act by 
recruiting more inflammatory cells to the site of damage 
thereby increasing the number of ROS. These are the key 
mediators involved in inflammation and include other 
molecules such as metabolites of arachidonic acid. 
Together they are capable of activating signal cascades and 
inducing changes in transcription factors. The transcription 
factors include NF-κB, HIF1-α, AP-1, NFAT and Nrf2. 
Other factors apart from chemokines and cytokines 
mediate the inflammatory response, these include COX-2, 
iNOS, differential expression of certain micro RNAs. All 
these contribute to an increase in the oxidative stress (19). 
When this state of increased ROS and oxidative stress 
persists it leads to the disruption of healthy surrounding 
cells and tissue and therefore leads to the incidence of 
cancer (20).  
3.1.1. In vitro studies 
Daphne genkwa also known as D.genkwa is a 
medicinal plant that has a large number of flavonoids 
associated with anti-inflammatory response. In a study 
conducted on HT-29 and SW-480 human colorectal cancer 
cells, it was concluded that flavonoids found in D.genkwa 
have an ability to regulate the immune system by 
inhibiting the production of inflammatory cytokines (21). 
in vitro studies have determined that flavonoids are 
capable of inhibiting the synthesis and activity of a variety 
of pro-inflammatory mediators such as cytokines, adhesion 
molecules, eicosanoids etc. Molecular mechanism includes 
the inhibition of various transcription factors such as the 
NF-kappaB, AP-1 and stimulation of Nrf2 (nuclear factor-
erythroid 2-related factor 2 (22). In a study conducted by 
Zhang et al (2014), it was determined that apigenin, which 
is a non-toxic natural flavonoid has the potential to inhibit 
lipopolysaccharide induced inflammation through multiple 
mechanisms. Macrophages were utilized and it was seen 
that apigenin inhibited LPS induced production of 
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cytokines such as IL-6, IL-1B and TNF-a. The production 
of IL-1B was inhibited by inhibition of caspase-1 through 
disruption of NLRP3 inflammasome assembly. mRNA 
stability was also reduced due to inhibition of ERK ½ 
activivation (23). The phosphatidylinositol-3 kinase 
(PI3K) family of signaling enzymes likely plays a key role 
in inflammation. The PI3k signaling cascade is involved in 
leukocyte recruitment and activation and is therefore 
thought to be involved in inflammation. Apigenin has also 
been reported to hinder the PI3k/Akt pathway in cancer 
cell lines. The data from a recent study conducted on 
breast cancer cell lines concluded that flavones such as 
apigenin and luteolin induced apoptosis and cell cycle 
arrest. Hs578T, MDA-MB-231 and MCF-7 breast cancer 
cells were used. The underlying mechanism was 
determined to be the induction of forkhead box O3 
(FOXO3a) expression. This subsequently elevated the 
expression of FOXO3a target genes, including the Cyclin-
dependent kinase inhibitors p21(Cip1) (p21) and p27(kip1) 
(p27), which increased the levels of activated poly(ADP) 
polymerase (PARP) and cytochrome c (24). Kadioglu et al 
(2015) reported anti-inflammatory effect of the flavonoid 
kaempferol against Nf-kB pathway proteins. Nf-kB is an 
important factor in the proliferation, inflammation and 
carcinogenesis. Kaempferol belongs to the flavonol class 
of flavonoids and its major sources include onions, 
cherries, broccoli, kale etc (25). 
A lot of flavonoids have been studied for their anti-
inflammatory effects in in vitro studies but there is still 
lack of evidence with regards to in vivo studies. in vitro 
studies focus only on pure doses of flavonoids 
administered therefore we cannot be completely sure about 
their effects in humans. This is because humans intake 
flavonoids indirectly from plant foods and not in pure 
doses. 
3.1.2. In vivo studies 
A number of studies have been conducted in animal 
models. In a recent experiment conducted by Tao et al 
(2015), Lewis-bearing C57BL/6 mice model was 
established and tumor growth was induced. 
Immunomodulatory factors were detected that confirmed 
the therapeutic effect of flavonoids present in Scutellaria 
barbata D. Don (SB). It was established that SB could 
inhibit tumor growth in vivo by regulating the immune 
system (26). Many flavonoids are used in combination 
with other molecules and exert a synergistic effect by 
enhancing or modulating the activity of the molecule being 
used. Quercitin, a well known flavonoid has been used 
along with B-carotene in order to modulate the activity of 
B-carotene against NF-kB induced inflammation in 
Mongolian gerbils (27). In another study, tricin, a 
flavonoid extracted from rice prevented the activation of 
the NF-kB and the JAK/STAT pathway in vivo. Activation 
of both STAT1 and STAT3 was inhibited via 
downregulation of JAK1 and JAK2 (28). 
3.2. Anti-cancer effects 
Prevention of cancer has been linked with the intake of 
a variety of plant foods. Wine drinkers are also considered 
at a lower risk of developing cancer than other people.  
3.2.1. In vitro studies 
Oncology reports published a study, Proanthocyanidins 
were investigated for their ability to stimulate programed 
cell death in human gastric cell line. The findings from this 
study suggest the use of Proanthocyanidins with autophagy 
inhibitors to significantly increase the rate of apoptosis and 
induce cytotoxicity (29). In agreement with this study, 
inhibition of esophageal adenocarcinoma by cranberry 
derived Proanthocyanidins (C-PAC) was investigated. C-
PAC induced caspase-independent cell death by inducing 
autophagy in acid-sensitive cell lines. A number of 
signaling pathways were also identified in other cell lines. 
In-activation of the PI3K/AKT/mTOR pathway, 
stimulation of pro-apoptotic proteins, modulation of 
MAPKs and G2-M cell cycle arrest were some of the key 
factors of action (30). Quercitin is a widely studied 
flavonoid attractive for its anti-cancer and anti-
proliferative activities. in vitro studies have acertained the 
anti-proliferarive outcome of quercetin against human 
colon adenocacinoma cells. The underlying mechanism 
was associated with a vital upsurge in the expression of the 
endocannabinoids receptor (CB1-R) following therapy 
with quercitin. This occurred because CB1-R is an 
estrogen responsive receptor and quercetin is similar in 
structure to estrogens so it interacts with CB1-R and 
regulates cell growth. To further clarify the underlying 
mechanism, principal molecular pathways were also 
investigated. Important survival signals like the 
PI3K/Akt/mTOR were inhibited, at the same time pro 
apoptotic JNK/JUN signaling pathways were induced. The 
metabolism of β-catenin was also modified. The 
interactive action of Quercitin with CB1-R was secured by 
means of anandamide (Met-F-AEA), a CB1-R agonist, 
SR141716, a CB1-R antagonist (31). A number of fruits 
have been considered as a valuable source of flavonoids 
and are recommended for the prevention of cancer. Yang S 
et al (2015) investigated the anticancer activities of 
flavonoids extracted from pink lady apples. The flavonoids 
were divided into two groups; peel-flavonoids and flesh-
flavonoids. It was seen that the both type of flavonoids 
were capable of inhibiting cancer cell growth in a dose 
dependent manner (32). 
3.2.2. In vivo studies 
Many flavonoids have been subjected to studies based 
on animal models. in vivo studies reinforce the efficacy of 
the drug being used and its underlying mechanism of 
action. Toxicity studies can also be conducted on animal 
models before any drug is administered to human cohorts. 
A number of in vivo studies have been successfully 
conducted that highlight the anti-cancer activity of 
flavonoids. Bioactive proanthocyanidins decrease the 
accumulation of B-catenin and thereby inhibit growth in 
human melanoma cells. Dietary administration of grape 
seed proanthocyanidins (GSPs), suppressed the growth of 
nude mice melanoma tumor xenografts.. Furthermore, 
xenograft growth was reduced in β-catenin-activated 
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Mel928 mice but remained unaffected in β-catenin-
inactivated Mel1011 mice (33). Swiss albino mice were 
utilized in one study where the anti-proliferative potential 
of hesperetin (HSP) was investigated against 
benzo(a)pyrene induced lung carcinogenesis. Pre- and 
post-treatment with HSP alleviated Lipid peroxidation, 
increased the level of antioxidants and decreased the 
expression of NF-κB, PCNA and CYP1A1 (34). Luteolin 
is a flavone that is found in a number of plant foods and is 
thought to possess anti-cancer activity. Cook et al (2016) 
demonstrated the ability of luteolin to suppress progestin- 
accelerated mammary tumors. Both low (1 mg/kg) and 
high (25 mg/kg) doses of luteolin considerably reduced 
progestin-dependent upsurges in tumor prevalance, while 
increasing tumor inactivity and decreasing the incidence of 
large (>300 mm3) mammary tumors. Immuno 
histochemical examination of tumor tissues showed that at 
all concentrations levels of VEGF were considerably 
reduced within the tumors (35). Chromatin acetylation is 
linked with epigenetics that play a crucial role in how 
people respond to drugs with relevance to gene expression 
in normal and diseased conditions. Luteolin, a flavonol, 
was found to inhibit this acetylation. The underlying 
mechanism was determined to be the competitive binding 
of luteolin to the acetyl CoA binding that inhibited p300 
acetyltransferase. Effects of luteolin were seen at multiple 
levels i.e. at the level of gene expression as well as at the 
level of miRNA processing. Tumor model of head and 
neck squamous cell carcinoma (HNSCC) was used. This 
xenografted model was treated with luteolin which led to a 
reduction in the size of the tumor within 4 weeks along 
with a decrease in the acetylation of histones (36). 
3.3. Anti-oxidant effects 
Anti-oxidants regulate the cellular levels of reactive 
oxygen species thereby preventing or reducing oxidative 
damage. Oxidative stress is the underlying cause for a 
number of diseases including cancer. Irregular levels of 
free radicals generated inside a cell can activate a number 
of signaling cascades that lead to cell-proliferation, cell 
cycle progression, inflammation and thus cancer. 
Flavonoids have been known to have anti-oxidant activity 
whereby they exert a protective effect on cells. A number 
of mechanisms are employed by flavonoids by which they 
reduce or prevent oxidative damage. 
1. Direct scavenging of ROS. 
2. Inhibition of superoxide anion production by 
inhibiting oxidases. 
3. Activation of anti-oxidant enzymes. 
4. Chelation of free metals; involved in oxygen 
metabolism. 
5. Alleviation of oxidative stress caused by nitric oxide 
(37). 
3.3.1. In vitro studies  
In a recent study published in the journal of 
photochemistry and photobiology, anti-oxidant activity of 
extracts from Galinsoga species was determined. The anti-
oxidant activity was examined by determining the 
scavenging property of these species. ROS scavenging is 
one of the mechanisms by which flavanoids exert their 
anti-oxidant activity. This activity was determined against 
two radicals generated in cell-free systems; O2- and 
H2O2. It was seen that ethanolic extracts from the herb 
exerted cytotoxic effects while the aqueous extracts 
exerted protective effects by inhibiting ROS generation. 
The aqueous extracts can therefore be labeled as effective 
photoprotectors (38). In a similar study conducted by Sung 
et al (2015), free-radical scavenging assays were used to 
determine the anti-oxidant activity of a perennial herb, 
Humulus japonicas. Extracts from this herb contain a 
number of bioactive compounds comprising luteolin, 
luteolin 7-glycoside, quercetin and quercitrin which 
effectively caused scavenging of ROS in in vitro and 
intracellular systems. Furthermore, experiments also 
demonstrated the upregulation of longevity-related 
proteins, sirtuin 1 and AMP-activated protein kinase. Thus 
it is safe to conclude that these flavanoids can be used as 
effective anti-aging and anti-oxidant compounds (39). 
Ashraf et al (2016), demonstrated the antioxidant 
activity of three extracts of Psidium guajava leaf; 
methanol, chloroform and hexane on three different cell 
lines (KBM5, SCC4 and U266). The hexane extract 
completely inhibited activation of TNF-a and Nf-kb 
activation in KBM5 cells and hence had antitumor and 
cytotoxic activity. All the extracts had different phenolic 
and flavonoid contents (40). 
3.3.2. In vivo studies 
Animal models have also been used to further 
determine the protective activity of different flavonoids 
although present in vivo studies are very limited. Wedelia 
chinensis is a traditional herb known to have 
hepatoprotective properties. This herb was seen to have 
neuroprotective effects in mice models by inhibiting 
oxidative stress- induced damage. Extracts from this herb 
contain luteolin that has been shown to have anti-cancer 
properties in multiple studies (41).  
Drug resistance during chemotherapy is one of the 
many hurdles that lead to poor prognosis in cancer 
patients. Isorhamnetin (IH), which is a metabolite of 
quercitin, was evaluated for its attenuating effect against 
chemoresistance. IH was administered along with 
capecitabine to enhance its efficacy in gastric cancer. Nude 
mice were used as tumor models. The results showed that 
IH enhanced the apoptotic effects of capecitabine and 
inhibited activation of the transcription factor Nf-kB. 
Whether administered alone or together with capecitabine, 
it showed anti-tumor activity and negatively regulated Nf-
kB and various other oncogenic biomarkers (42).  
4. CONCLUSION 
Many plant-derived and natural products are being 
tested for their anti-cancer activities. Several of these 
agents are in clinical trials all over the world such as taxol, 
vinblastine, vincristine, etoposide etc (14). Other 
flavonoids that show great promise include quercitin, 
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hesperitin, luteolin, proanthocyanidins. Flavonoids exhibit 
anti-oxidant, anti-inflammatory, anti-tumor, anti-
angiogenesis activity. Flavonoids modulate the biological 
events in cancer progression by effecting different 
signaling cascades. They have been shown to inhibit 
several key transcriptional factors and are capable of 
inducing apoptosis and cell death. Quercitin, a well-
studied flavonoid induced G2/M phase cell cycle halt and 
mitochondrial programed cell death through a P-53 
dependent mechanism in HeLa cells (human cervical 
cancer cells) (43).  
Further studies and biochemical tests should be carried 
out to validate the relationship between the structure and 
function of specific flavonoids. This validation is 
important if flavonoids are to be used commercially for the 
treatment of cancer. Moreover, the lack of epidemiological 
studies that focus on the intake of pure doses of 
flavonoids, is also a major area that lacks data. 
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